Clinical Trial Update: A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating the CODOX-M/IVAC chemotherapy regimen for relapsed or refractory acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• METHOTREXATE (METHOTREXATE)
• Vincristine (vincristine)

Snippet

Sponsor: Cooperative Study Group A for Hematology | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: UNKNOWN